Skip to content
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Investigator Initiated
Research
Contact Us
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Investigator Initiated
Research
Contact Us
Search
Read about Endologix
in the news
Embrace the evidence.
The Latest:
Jul 9
Endologix Announces that Scott Huennekens Joins Board of Directors
See Release
All News
Archives
All
2025
2024
2023
2022
2021
Jun 18
Endologix Appoints Graham Phillips as Chief Operating Officer
May 13
One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)
Mar 14
Endologix to Present at Upcoming LSI US ’24 Emerging Medtech Summit
Mar 5
Endologix Appoints Mike Mathias as Chief Commercial Officer
Feb 29
Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next
